Burning Rock Biotech annual r&d spending
2020
2021
2022
2023
2024
2025
Burning Rock Biotech R&D Spending Growth & History (BNR)
Burning Rock Biotech's r&d spending was $23.8M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $23.8M | −$8.0M | −25.19% |
| 2024 | 2024-12-31 | $31.8M | −$17.1M | −34.89% |
| 2023 | 2023-12-31 | $48.9M | −$12.3M | −20.09% |
| 2022 | 2022-12-31 | $61.2M | $3.4M | +5.96% |
| 2021 | 2021-12-31 | $57.7M | $17.3M | +42.70% |
| 2020 | 2020-12-31 | $40.5M | — | — |
Burning Rock Biotech r&d spending trends
Over the last five fiscal years, Burning Rock Biotech's r&d spending decreased from $40.5M to $23.8M, a change of −$16.6M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗